ADD/ ADHD new drug Atomoxetine shows promise in clinical trials

[ Follow Ups ] [ Post Followup ] [ Stephanie's Message Board ] [ FAQ ]

Posted by Stephanie Palmer (158.252.242.90) on August 24, 2002 at 11:29:49:

There is a new drug (Atomoxetine) which is showing much promise in clinical trials. Atomoxetine is a potent, noradrenergic specific reuptake inhibitor (NSRI) that has been studied in over 1800 children and over 250 adults. This agent is awaiting FDA approval.

Please see the article "Pharmacologic Treatment of Attention-Deficit Hyperactivity Disorder in Children" written by Thomas Spencer, MD. This article is posted on Medscape Released on June 28, 2002 and is valid for credit through June 27, 2003.

To view the article you must be a member of www.medscape.com. If you aren't - no worries the registration for the site is about 8 questions. The article can be found at:
http://www.medscape.com/viewprogram/1927

Follow Ups:

Post a Followup

Name:
E-Mail:

Subject: Re: ADD/ ADHD new drug Atomoxetine shows promise in clinical trials

Comments:
> There is a new drug (Atomoxetine) which is showing much promise in clinical trials. Atomoxetine is a potent, noradrenergic specific reuptake inhibitor (NSRI) that has been studied in over 1800 children and over 250 adults. This agent is awaiting FDA approval. > Please see the article "Pharmacologic Treatment of Attention-Deficit Hyperactivity Disorder in Children" written by Thomas Spencer, MD. This article is posted on Medscape Released on June 28, 2002 and is valid for credit through June 27, 2003. > To view the article you must be a member of www.medscape.com. If you aren't - no worries the registration for the site is about 8 questions. The article can be found at: > http://www.medscape.com/viewprogram/1927

[ Follow Ups ] [ Post Followup ] [ Stephanie's Message Board ] [ FAQ ]